等待开盘 08-25 09:30:00 美东时间
-0.030
-2.05%
InMed Pharmaceuticals ( ($INM) ) has issued an update. On July 22, 2026, Mentar...
07-23 04:49
WALTHAM, Mass., July 22, 2026 /PRNewswire/ -- Mentari Therapeutics, Inc. ("Mentari"), a privately-held biotechnology company developing therapies for migraine prevention, today announced a $...
07-22 19:00
InMed Pharmaceuticals ( ($INM) ) has provided an update. On July 6, 2026, InMed...
07-11 04:32
InMed agrees to merge with Mentari Therapeutics to advance migraine drug candidates backed by $290 million in financing.
05-19 22:05
Canadian pharmaceutical company InMed Pharmaceuticals (INM) added ~170% in the premarket on Tuesday after announcing an all-stock merger agreement with migraine drug developer Mentari Therapeutics to ...
05-19 20:51
Upon consummation of the transaction contemplated by the Agreement, the combined entity will operate as Mentari Therapeutics and trade on the Nasdaq Capital Market under a new ticker symbol. Mentari's parallel lead
05-19 20:07
InMed Pharmaceuticals ( ($INM) ) just unveiled an announcement. On May 6, 2026,...
05-07 18:52
InMed Pharmaceuticals press release (INM): Q3 GAAP EPS of -$0.73. As of March 31, 2026, the Company's cash, cash equivalents and short-term investments were $5.2 million, which compares to $10.8 milli...
05-07 06:08